Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed) vs Research Centers in Minority Institutions (RCMI) Coordinating Center (U24 - Clinical Trial Optional)
Side-by-side comparison of two grants.
| Attribute | Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed) | Research Centers in Minority Institutions (RCMI) Coordinating Center (U24 - Clinical Trial Optional) |
|---|---|---|
| Type | Grant | Grant |
| Funding amount | — | $3.5M |
| Deadline | Closes 2027-12-23 | Closes in 11 days |
| Region | US | US |
| Sector | Health | Health |
| Funder | National Institutes of Health | National Institutes of Health |
| Who it's for | researchers, government | researchers, government |